Back to Journals » Therapeutics and Clinical Risk Management » Volume 11
Perspectives
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Integrating risk minimization planning throughout the clinical development and commercialization lifecycle: an opinion on how drug development could be improved
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
17,827 | Dovepress* | 15,375+ | 2,292 | 17,667 | |
PubMed Central* | 2,452 | 541 | 2,993 | ||
Totals | 17,827 | 2,833 | 20,660 | ||
*Since 26 February 2015 +Since July 2016 |
View citations on PubMed and Google Scholar